The world's most advanced human tissue and disease models
MIMETAS creates advanced human tissue and disease models using organ-on-a-chip technology to enable faster development of safer and more effective therapies. Their OrganoPlate® platform is the world's first mass-produced, quality-controlled organ-on-a-chip system enabling physiologically relevant 3D cell culture without pumps or tubing. Top pharmaceutical companies worldwide use MIMETAS technology to reduce pipeline risks and advance drug programs.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountJan 2020
Create a free account to see which investors have funded this company.
Create Free Account
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...
